Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2005-4-5
pubmed:abstractText
To evaluate the efficacy and safety of once-daily saquinavir-soft-gel-capsules/ritonavir (SQV-SGC/RTV) 1600 mg/100 mg plus dual nucleoside reverse transcriptase inhibitors (NRTIs) in HIV-infected patients with plasma viral load (pVL) <50 HIV-1 RNA copies/mL following 3 years of antiretroviral therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1464-2662
pubmed:author
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
122-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:15807718-Adult, pubmed-meshheading:15807718-Antiretroviral Therapy, Highly Active, pubmed-meshheading:15807718-CD4 Lymphocyte Count, pubmed-meshheading:15807718-Drug Administration Schedule, pubmed-meshheading:15807718-Drug Therapy, Combination, pubmed-meshheading:15807718-Female, pubmed-meshheading:15807718-Follow-Up Studies, pubmed-meshheading:15807718-HIV Infections, pubmed-meshheading:15807718-HIV Protease Inhibitors, pubmed-meshheading:15807718-HIV-1, pubmed-meshheading:15807718-Humans, pubmed-meshheading:15807718-Male, pubmed-meshheading:15807718-RNA, Viral, pubmed-meshheading:15807718-Retrospective Studies, pubmed-meshheading:15807718-Reverse Transcriptase Inhibitors, pubmed-meshheading:15807718-Ritonavir, pubmed-meshheading:15807718-Saquinavir, pubmed-meshheading:15807718-Triglycerides, pubmed-meshheading:15807718-Viral Load
pubmed:year
2005
pubmed:articleTitle
The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.
pubmed:affiliation
The HIV Netherlands Australia Thailand Research Collaborative (HIVNAT), The Thai Red Cross AIDS Research Center, Bangkok, Thailand. Peter.Cardiello@post.harvard.edu
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't